US Health and Human Services Secretary Dr Tom Price has named Dr Brenda Fitzgerald, as the 17th Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR).
The CDC is one of the top federal public health agency, which, under President Donald Trump’s proposed budget, faces a funding cut of $1.2 billon.
“Today, I am extremely proud and excited to announce Dr Brenda Fitzgerald as the new Director of the CDC,” said Secretary Price, adding: “Having known Dr Fitzgerald for many years, I know that she has a deep appreciation and understanding of medicine, public health, policy and leadership - all qualities that will prove vital as she leads the CDC in its work to protect America’s health 24/7. We look forward to working with Dr Fitzgerald to achieve President Trump's goal of strengthening public health surveillance and ensuring global health security at home and abroad.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze